G & W Laboratories recalls
FDA enforcement reports naming G & W Laboratories Inc as the recalling firm.
- Recall reports
- 6
- Class I (serious)
- 0
- Most recent report
- Feb 14, 2018
- Feb 14, 2018Ciclopirox Olamine Cream USP, 0Drug · G & W Laboratories, Inc.Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.Class III
- Jul 12, 2017G & W Clobetasol Propionate Ointment 0Drug · G & W Laboratories, Inc.Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product.Class III
- Apr 12, 2017Ciclopirox Olamine Cream USP, 0Drug · G & W Laboratories, Inc.Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.Class III
- Mar 22, 2017Clindamycin Phosphate Topical Solution USP, 1%, packaged in a) 30 mL applicator bottles…Drug · G & W Laboratories, Inc.CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.Class III
- Mar 8, 2017Indocin (Indomethacin) suppositories, USP, 50 mg, laminate strips packed in boxes of 30…Drug · G & W Laboratories, Inc.Failed Impurities/Degradation Specifications: Out of specification (OOS) for total impurity and out of trend for known impurity results encountered during stability testing.Class II
- Jan 8, 2014G & W Fluocinolone Acetonide Cream USP 0Drug · G & W Laboratories IncFailed Content Uniformity Specifications; at the 18 month time point.Class III